Round Table: Detecting and monitoring progressionHarry A. Quigley

摘要

Dr Quigley: I am going to stick to questions that would be highly relevant to what you are going to deal with next Monday morning when you sit down to see the next glaucoma patient, because probably thirty to forty percent of the patients you see in a general ophthalmology clinic have a glaucoma related problem. One of the things you might need to talk to your glaucoma patients about is what is the likelihood that they are going to go blind. Or to put it in a more useful way, what is the likelihood that the average glaucoma patient is going to get worse in a given year in one eye? Dr Johnson, have you ever given thought to that question? Just as a proportion for example, what do you think is the chance that the average glaucoma patient under standard treatment being given by these fine doctors out here in the United States is going to have a worsening of visual field in one eye or the other one in a given year of follow-up? Is it a high chance? Is it a low chance? The world's literature does have some answers, and I will be happy to provide that later. Dr Johnson, what do you think the chances are?